| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 356–67
|
|
|
2019
|
7 |
11 |
p. e22
|
artikel
|
| 2 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 855–65
|
|
|
2019
|
7 |
11 |
p. e22
|
artikel
|
| 3 |
Diabetes clusters and risk of diabetes-associated diseases
|
Liu, Shufang
|
|
2019
|
7 |
11 |
p. 828
|
artikel
|
| 4 |
Diabetes clusters and risk of diabetes-associated diseases – Authors' reply
|
Zaharia, Oana P
|
|
2019
|
7 |
11 |
p. 828-829
|
artikel
|
| 5 |
Diabetic kidney disease 2.0: the treatment paradigm shifts
|
Gilbert, Richard E
|
|
2019
|
7 |
11 |
p. 820-821
|
artikel
|
| 6 |
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
|
Fleseriu, Maria
|
|
2019
|
7 |
11 |
p. 855-865
|
artikel
|
| 7 |
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
|
Lingvay, Ildiko
|
|
2019
|
7 |
11 |
p. 834-844
|
artikel
|
| 8 |
Let's talk about sex
|
|
|
2019
|
7 |
11 |
p. 817
|
artikel
|
| 9 |
Maternal pre-pregnancy obesity and preterm birth: more explorations needed
|
Yuan, Yuan
|
|
2019
|
7 |
11 |
p. 829
|
artikel
|
| 10 |
Maternal pre-pregnancy obesity and preterm birth: more explorations needed – Authors' reply
|
Liu, Buyun
|
|
2019
|
7 |
11 |
p. 829-830
|
artikel
|
| 11 |
Menopausal hormone therapy: is there cause for concern?
|
Davis, Susan R
|
|
2019
|
7 |
11 |
p. 825-827
|
artikel
|
| 12 |
Metabolic health in the Middle East and north Africa
|
Azizi, Fereidoun
|
|
2019
|
7 |
11 |
p. 866-879
|
artikel
|
| 13 |
Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice
|
Garg, Ankit
|
|
2019
|
7 |
11 |
p. 880-886
|
artikel
|
| 14 |
Research digest: new horizons in heart failure therapy
|
Sattar, Naveed
|
|
2019
|
7 |
11 |
p. 832
|
artikel
|
| 15 |
SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes?
|
Scheen, André J
|
|
2019
|
7 |
11 |
p. 818-820
|
artikel
|
| 16 |
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
|
Neuen, Brendon L
|
|
2019
|
7 |
11 |
p. 845-854
|
artikel
|
| 17 |
55th Annual Meeting of the European Association for the Study of Diabetes
|
Bennet, Neil
|
|
2019
|
7 |
11 |
p. 831
|
artikel
|
| 18 |
The CGM grey market: a reflection of global access inequity
|
Onisie, Oana
|
|
2019
|
7 |
11 |
p. 823-825
|
artikel
|
| 19 |
The complexity of obesity
|
Flint, Stuart W
|
|
2019
|
7 |
11 |
p. 833
|
artikel
|
| 20 |
The sinister side of Cushing's therapy
|
Grossman, Ashley
|
|
2019
|
7 |
11 |
p. 822-823
|
artikel
|
Tijdschrift beschrijving